During the past decade, Novant Health Cancer Institute - Huntersville conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 20 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 19 clinical trials were completed. i.e. 211.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novant Health Cancer Institute - Huntersville" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "NRG Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Cancer Institute - Huntersville" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Novant Health Cancer Institute - Huntersville" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (4 trials), "Invasive Breast Carcinoma" (4 trials) and "Ovarian Serous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Novant Health Cancer Institute - Huntersville" in a lesser frequency.

Most popular intervention types in "Novant Health Cancer Institute - Huntersville" are "Drug" (43 trials), "Other" (39 trials), "Biological" (23 trials), "Procedure" (13 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (13 trials), "Questionnaire Administration" (11 trials), "Docetaxel" (9 trials) and "Nivolumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Cancer Institute - Huntersville" are 37 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Novant Health Cancer Institute - Huntersville". undefined are not yet recruiting, 13 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Novant Health Cancer Institute - Huntersville, 2 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Cancer Institute - Huntersville, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".